Effect of sulfonylurea agents on reverse cholesterol transport in vitro and vivo

J Atheroscler Thromb. 2011;18(6):513-30. doi: 10.5551/jat.7641. Epub 2011 Jun 3.

Abstract

Aim: Reverse cholesterol transport (RCT) is a critical mechanism for the anti-atherogenic property of HDL. The inhibitory effect of the sulfonylurea agent (SUA) glibenclamide on ATP binding-cassette transporter (ABC) A1 may decrease HDL function but it remains unclear whether it attenuates RCT in vivo. We therefore investigated how the SUAs glibenclamide and glimepiride affected the functionality of ABCA1/ABCG1 and scavenger receptor class B type I (SR-BI) expression in macrophages in vitro and overall RCT in vivo.

Methods: RAW264.7, HEK293 and BHK-21 cells were used for in vitro studies. To investigate RCT in vivo, 3H-cholesterol-labeled and acetyl LDL-loaded RAW264.7 cells were injected into mice.

Results: High dose (500µM) of glibenclamide inhibited ABCA1 function and apolipoprotein A-I (apoA-I)-mediated cholesterol efflux, and attenuated ABCA1 expression. Although glimepiride maintained apoA-I-mediated cholesterol efflux from RAW264.7 cells, like glibenclamide, it inhibited ABCA1-mediated cholesterol efflux from transfected HEK293 cells. Similarly, the SUAs inhibited SR-BI-mediated cholesterol efflux from transfected BHK-21 cells. High doses of SUAs increased ABCG1 expression in RAW264.7 cells, promoting HDL-mediated cholesterol efflux in an ABCG1-independent manner. Low doses (0.1-100 µM) of SUAs did not affect cholesterol efflux from macrophages despite dose-dependent increases in ABCA1/G1 expression. Furthermore, they did not change RCT or plasma lipid levels in mice.

Conclusion: High doses of SUAs inhibited the functionality of ABCA1/SR-BI, but not ABCG1. At lower doses, they had no unfavorable effects on cholesterol efflux or overall RCT in vivo. These results indicate that SUAs do not have adverse effects on atherosclerosis contrary to previous findings for glibenclamide.

MeSH terms

  • ATP-Binding Cassette Transporters / antagonists & inhibitors
  • ATP-Binding Cassette Transporters / genetics
  • ATP-Binding Cassette Transporters / metabolism*
  • Animals
  • Biological Transport
  • Blotting, Western
  • Cells, Cultured
  • Cholesterol / metabolism*
  • Cricetinae
  • Glyburide / pharmacology*
  • HEK293 Cells
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • In Vitro Techniques
  • Liver / cytology
  • Liver / drug effects
  • Liver / metabolism
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Macrophages, Peritoneal / cytology
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Scavenger Receptors, Class B / antagonists & inhibitors
  • Scavenger Receptors, Class B / genetics
  • Scavenger Receptors, Class B / metabolism*

Substances

  • ATP-Binding Cassette Transporters
  • Hypoglycemic Agents
  • RNA, Messenger
  • Scavenger Receptors, Class B
  • Cholesterol
  • Glyburide